Cite
Toh HC, Wang WW, Chia WK, et al. Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients. Clin Cancer Res. 2009;15(24):7726-7736doi: 10.1158/1078-0432.CCR-09-1537.
Toh, H. C., Wang, W. W., Chia, W. K., Kvistborg, P., Sun, L., Teo, K., Phoon, Y. P., Soe, Y., Tan, S. H., Hee, S. W., Foo, K. F., Ong, S., Koo, W. H., Zocca, M. B., & Claesson, M. H. (2009). Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients. Clinical cancer research : an official journal of the American Association for Cancer Research, 15(24), 7726-7736. https://doi.org/10.1158/1078-0432.CCR-09-1537
Toh, Han Chong, et al. "Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15,24 (2009): 7726-7736. doi: https://doi.org/10.1158/1078-0432.CCR-09-1537
Toh HC, Wang WW, Chia WK, Kvistborg P, Sun L, Teo K, Phoon YP, Soe Y, Tan SH, Hee SW, Foo KF, Ong S, Koo WH, Zocca MB, Claesson MH. Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients. Clin Cancer Res. 2009 Dec 15;15(24):7726-7736. doi: 10.1158/1078-0432.CCR-09-1537. PMID: 19996212.
Copy
Download .nbib